DPRK copes with new diseases with full alertness, strengthens anti-epidemic measures
Main efforts are being directed to the anti-epidemic work to thoroughly block the inflow and space of spread of new infectious diseases including o mutated virus and monkey smallpox which are spreading rapidly around the world.
While paying sharp attention to the outbreak and spread of malignant diseases in neighbouring countries and regions, the central emergency anti-epidemic sector makes a detailed survey and control of multiple-blockade performance for the ground, sea and air on a regular basis, and takes powerful measures lest there should be any slightest space for the inflow of new mutated viruses.
Timely practical measures are taken to rationally select and control anti-epidemic grades in a mobile way and reconfirm the quarantine and blocking standards of epidemiologically dangerous objects.
Proactive research activities are conducted to prevent the occurrence of new infectious diseases, including the development of antigen of malignant virus and antibody test reagent.
Research groups have conducted intensive sample tests on fever cases and intensified studies for clarifying the reason of degradation of cells. They entered the stage of comprehensive analysis of test results after completing the biological products approval test and clinical introduction test for the antibody test method.
A new technology has been developed to produce antiseptic solution, which is made of locally-abundant materials, which does not do harm to the human body and whose germ and virus sterilizing effect is ten times higher than the previous antiseptic solution. Accordingly, device production and manufacturing methods were established and they are being introduced into anti-epidemic and preventive and curative units at all levels.
With monitoring, information, epidemiological survey and experimental test being intensified across the country, relevant research institutions observe the outbreak and spread of enteric infectious disease in correlation with malignant virus varieties, conduct research into the clinical characteristics and course of disease and build a database in a more detailed way, and intensify the preliminary survey of new mutated virus.
KCNA-THE PYONGYANG TIMES